The federal government and the two groups that sued it separately to force it to issue long delayed 340B administrative dispute resolution (ADR) regulations agreed last night to keep stays in place in both lawsuits until Jan. 3, 2022. Meanwhile, drug manufacturer AstraZeneca is seeking a stay in one set of ADR proceedings and the panel assigned to hear another set of ADR proceedings has issued a scheduling order.
The National Association of Community Health Centers (NACHC) is one of the two groups that sued to compel the U.S. Health and Human Services Department (HHS) to issue the 340B ADR final rule, which HHS did in December 2020 (the rule took effect in January 2021). Ryan White Clinics for 340B Access (RWC-340B) and three community health centers working with it make up the other group that sued.
The federal government and the two groups that sued it separately to force it to issue long delayed 340B administrative dispute resolution (ADR) regulations agreed last night to keep stays in place in both lawsuits until Jan. 3, 2022. Meanwhile, drug manufacturer AstraZeneca is seeking a stay in one set of ADR proceedings and the panel assigned to hear another set of ADR proceedings has issued a scheduling order.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
